Home › Funds › PFM Health Sciences, LP › BIO
PFM Health Sciences, LP position in BIO
BIO RAD LABS INC · Industrials
PFM Health Sciences, LP reported holding 20,283 shares of BIO (BIO RAD LABS INC) in its Q3 2026 13F filing — a position valued at US$7.7M, representing 0.78% of its reported portfolio and ranking #47 among its reported holdings. PFM Health Sciences, LP has disclosed BIO holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's BIO position evolved
PFM Health Sciences, LP first disclosed a stake in BIO in Q2 2026 at 13,995 shares (US$4.1M). The position peaked in Q3 2026 at 20,283 shares, worth US$7.7M. Across 2 filings, PFM Health Sciences, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 20,283 shares valued at US$7.7M — an increase of 6,288 shares quarter over quarter.. Notable position changes include a 45% increase in Q3 2026 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 13.99K | $4.11M | New |
| Q3 2026 | 20.28K | $7.66M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIO and 13F data
BIO (BIO RAD LABS INC) is a Industrials company. 28 other funds we track also report a position in BIO — the largest reported positions include First Eagle Investment Management (US$927.5M), ARIEL INVESTMENTS, LLC (US$298.1M), EARNEST PARTNERS LLC (US$214.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIO
- First Eagle Investment Management 2.46M sh · $927.50M · Q3 2026
- ARIEL INVESTMENTS, LLC 789.34K sh · $298.14M · Q3 2026
- EARNEST PARTNERS LLC 567.82K sh · $214.47M · Q3 2026
- First Pacific Advisors, LP 269.08K sh · $101.63M · Q3 2026
- NOMURA HOLDINGS INC 328.90K sh · $96.57M · Q2 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held BIO?
PFM Health Sciences, LP has disclosed BIO holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is PFM Health Sciences, LP's current position in BIO?
As of Q3 2026, PFM Health Sciences, LP holds 20.28K shares of BIO (BIO RAD LABS INC), valued at $7.66M, representing 0.78% of its reported portfolio and ranking #47.
Has PFM Health Sciences, LP been buying or selling BIO?
In the latest 13F filing (Q3 2026), PFM Health Sciences, LP increased its position in BIO. The position peaked in Q3 2026 at 20.28K shares.
Which other funds hold BIO?
Other major institutional holders of BIO include First Eagle Investment Management, ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.